GlassScriptPhysician profile
Caitlin E Martin
NPI 1669859310
$1,316.74
in general payments reported to CMS, 2019-2025
17 companies · $842 in 2025
The $842 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2021: $13.27 · 2022: $203 · 2023: $28.87 · 2024: $75.84 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $257.50 | 2019-2022 | |
| Hologic Sales and Service, LLC | $206.62 | 2025 | Aptima, Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medline Industries LP | $191.51 | 2024-2025 | |
| Biogen, INC. | $149.16 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $127.92 | 2025 | Slynd |
| Mayne Pharma Commercial LLC | $95.41 | 2025 | |
| Conmed Corporation | $71.43 | 2019 | |
| Abbvie INC. | $34.39 | 2021-2025 | |
| Applied Medical Resources Corporation | $28.87 | 2023 | |
| Masimo Corporation | $27.77 | 2022 | |
| Daiichi Sankyo INC. | $26.02 | 2025 | Injectafer |
| Sumitomo Pharma America, INC. | $24.08 | 2025 | Myfembree |
| Millicent US INC | $23.12 | 2025 | Femlyv, Intrarosa |
| Davol INC. | $18.91 | 2025 | Arista |
| Pacira Pharmaceuticals Incorporated | $14.78 | 2025 | Exparel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.43 | 2024 | Truclear |
| Organon LLC | $5.82 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.